Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT Serotonin Receptor Antagonists.

We have designed and synthesized a series of 60 new 5- and 7-hydroxycoumarin derivatives bearing the piperazine moiety with the expected binding to 5-HT and 5-HT receptors. Molecular docking of all investigated compounds revealed subnanomolar estimates of 5-HTR K for three ligands and 5-HTR Ki for one ligand as well as numerous low nanomolar estimates of K for both receptors. Intrigued by these results we synthesized all 60 new derivatives using microwave-assisted protocols. We show that three new compounds show a relatively high antagonistic activity against the 5HT receptor, although lower than the reference compound WAY-100635. These compounds also showed relatively low binding affinities to the 5-HT receptor. We also provide a detailed structure-activity analysis of this series of compounds and compare it with previously obtained results for an exhaustive series of coumarin derivatives.